| Home > Institute Collections > W500 > Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy. |
| Journal Article | DKFZ-2025-02460 |
2022
Frontiers Media
Lausanne
Keyword(s): Humans (MeSH) ; Neoplasms: drug therapy (MeSH) ; Receptors, Tumor Necrosis Factor, Type I (MeSH) ; Receptors, Tumor Necrosis Factor, Type II (MeSH) ; Tumor Necrosis Factor-alpha (MeSH) ; TNFR1 ; TNFR2 ; cancer ; personalized therapy ; tumor necrosis factor α/TNFα ; Receptors, Tumor Necrosis Factor, Type I ; Receptors, Tumor Necrosis Factor, Type II ; Tumor Necrosis Factor-alpha
|
The record appears in these collections: |